Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia.

c-Met is a tyrosine kinase receptor for hepatocyte growth factor and suggested to be involved in oncogenesis ormetastatic phenotypes in many malignancies. Adult T-cell leukemia (ATL) is a neoplasia characterized by massive invasion of the leukemic cells into various organs. Recently, we have reported frequent hepatic involvement and the relationship between liver invasion and the poor prognosis in ATL. In the present study, we investigated the expression of c-Met in ATL cells and its relation to liver dysfunction. In three of four human T-cell lymphotrophic virus-I-positive T-cell lines, c-Met was expressed both at mRNA and protein levels, whereas it was not expressed in human T-cell lymphoma virus-I-negative T-cell lines. The expressed c-Met should be functional, because hepatocyte growth factor could induce the autophosphorylation of c-Met. Although the viral-transactivating protein Tax has been shown to be involved in the deregulated expression of cellular genes, Tax mRNA was not detected in c-Met mRNA-expressed cell lines. From freshly isolated peripheral blood mononuclear cells, the expression of c-Met mRNA was detected in 10 of 16 ATL patients but not from healthy individuals. Finally, serum transaminase levels were significantly increased in c-Met-positive ATL cases, and all of the infiltrated c-Met-positive cells into liver were shown to be multilobularly nucleated phenotype. Taken together, these data suggest for the first time that c-Met is involved in the liver invasive phenotype of ATL.

[1]  G. Woude,et al.  Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis , 1996, Journal of Molecular Medicine.

[2]  T. Matsuyama,et al.  Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation , 2001, Oncogene.

[3]  S. Pileri,et al.  Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. , 2001, Blood.

[4]  L. Naldini,et al.  Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function1 , 2001, Journal of Immunology.

[5]  K. Furge,et al.  Met receptor tyrosine kinase: enhanced signaling through adapter proteins , 2000, Oncogene.

[6]  Masao Tomonaga,et al.  Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL) , 2000, Japanese journal of cancer research : Gann.

[7]  P. Schirmacher,et al.  Hepatocyte growth factor-stimulated invasiveness of monocytes. , 2000, Blood.

[8]  P. Allavena,et al.  Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells , 2000 .

[9]  G. Gaidano,et al.  The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma , 2000, Leukemia.

[10]  S. Fujita,et al.  Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. , 2000, Blood.

[11]  E. Gherardi,et al.  Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met* , 1999, The Journal of Biological Chemistry.

[12]  S. Fujita,et al.  SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin. , 1998, Journal of immunology.

[13]  H. Drexler,et al.  Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. , 1998, Leukemia research.

[14]  Fukao,et al.  Expression and Function of c‐Met, a Receptor for Hepatocyte Growth Factor, During T‐Cell Development , 1998, Scandinavian journal of immunology.

[15]  C. Figdor,et al.  Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. , 1998, Blood.

[16]  P. Schirmacher,et al.  Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. , 1997, Blood.

[17]  M. Tomonaga,et al.  Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma. , 1997, Leukemia & lymphoma.

[18]  T. Taher,et al.  Paracrine Regulation of Germinal Center B Cell Adhesion through the c-Met–Hepatocyte Growth Factor/Scatter Factor Pathway , 1997, The Journal of experimental medicine.

[19]  K. Matsumoto,et al.  Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. , 1997, Blood.

[20]  D. de Jong,et al.  Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins , 1997 .

[21]  A. Waage,et al.  Hepatocyte growth factor and its receptor c-met in multiple myeloma. , 1996, Blood.

[22]  K. Yoshida,et al.  Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells , 1996, The Journal of experimental medicine.

[23]  A. Waage,et al.  Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines* , 1996, The Journal of Biological Chemistry.

[24]  Q. Chen,et al.  Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[25]  M. Tomonaga,et al.  Features of the cytokines secreted by adult T cell leukemia (ATL) cells. , 1996, Leukemia & lymphoma.

[26]  Yuetsu Tanaka,et al.  The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells , 1996, The Journal of experimental medicine.

[27]  P. Lollini,et al.  Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. , 1996, Oncogene.

[28]  B. Elliott,et al.  Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. , 1996, The American journal of pathology.

[29]  P. Boros,et al.  Hepatocyte growth factor: a multifunctional cytokine , 1995, The Lancet.

[30]  D. Adams,et al.  Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. V. Vande Woude,et al.  Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  V. Diehl,et al.  The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. , 1994, Leukemia research.

[33]  H. Gralnick,et al.  Increased Expression of α4β1 and α5β1 Integrins on HTLV-I-Infected Lymphocytes , 1993 .

[34]  G. V. Vande Woude,et al.  Met expression and sarcoma tumorigenicity. , 1993, Cancer research.

[35]  S. Hirohashi,et al.  Immunohistochemical Detection of Hepatocyte Growth Factor/Scatter Factor in Human Cancerous and Inflammatory Lesions of Various Organs , 1993, Japanese journal of cancer research : Gann.

[36]  A. Imura,et al.  E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells. , 1993, Blood.

[37]  T. Nakamura,et al.  Hepatocyte growth factor stimulates growth of hematopoietic progenitor cells. , 1993, Biochemical and biophysical research communications.

[38]  M. Tamura,et al.  Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. , 1993, The Journal of biological chemistry.

[39]  M. Pierotti,et al.  Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. , 1992, Oncogene.

[40]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[41]  P. Comoglio,et al.  The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors , 1991, International journal of cancer.

[42]  T. Sugimura,et al.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Kannagi,et al.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. , 1982, Science.

[44]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[45]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[46]  E. Jaffe,et al.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. , 1980, Blood.